Vedolizumab (Entyvio) and infliximab (Remicade) led to mostly similar 1-year outcomes in patients with ulcerative colitis ...

Researchers have uncovered potentially diagnostic gut microbiome signatures and metabolic pathways associated specifically ...

Upadacitinib may offer superior disease management than tofacitinib for patients with ulcerative colitis. Learn more.

A simple, non-invasive treatment focused on the ears could one day provide relief for people with ulcerative colitis, a UM ...

Topline Clinical Data Demonstrates Activity of SOR102 Across Multiple Clinical Endpoints Supporting Advancement to Phase 2 ...

An appendectomy may help improve or prevent symptoms in people with ulcerative colitis. However, evidence on this topic is mixed, and more research is needed. Ulcerative colitis (UC) is a type of ...

anti-IL-7 Receptor Lusvertikimab in Ulcerative Colitis accepted for Oral Presentation and selected amongst the Top 10 oral ...

Teva Pharmaceuticals and Sanofi announced positive results in a Phase 2b trial of their drug for ulcerative colitis and Crohn ...

The top gastroenterology biosimilar news from 2024 highlight fluctuations in the adalimumab biosimilar market throughout the ...

Israel's Teva Pharmaceutical Industries and French drugmaker Sanofi said a study of a drug to treat ulcerative colitis and ...

Nutrients specific to the Mediterranean diet could help with symptom management in inflammatory bowel disease, evidence ...

The search for effective therapies in ulcerative colitis, a chronic inflammatory condition affecting the colon and rectum ...